Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
J Neurosurg
; 124(1): 51-8, 2016 Jan.
Article
en En
| MEDLINE
| ID: mdl-26162034
Palabras clave
ACA = anterior cerebral artery; BA = basilar artery; BP = blood pressure; CBF = cerebral blood flow; CCT = cranial computed tomography; CVS; CVS = cerebral vasospasm; DIND; DIND = delayed ischemic neurological deficit; DSA = digital subtraction angiography; GCS = Glasgow Coma Scale; HES = hydroxyethyl starch; HH = Hunt and Hess; ICA = internal carotid artery; ICP = intracranial pressure; MAP = mean arterial blood pressure; MCA = middle cerebral artery; MTG = molsidomine treatment group; NO; NO = nitric oxide; SAH = subarachnoid hemorrhage; STG = standard therapy group; TCD = transcranial Doppler; VA = vertebral artery; mNIHSS = modified National Institutes of Health Stroke Scale; mRS = modified Rankin Scale; molsidomine; subarachnoid hemorrhage; vascular disorders; vasospasm
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Hemorragia Subaracnoidea
/
Vasodilatadores
/
Molsidomina
/
Isquemia Encefálica
/
Infarto Encefálico
/
Vasoespasmo Intracraneal
/
Enfermedades del Sistema Nervioso
Tipo de estudio:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Neurosurg
Año:
2016
Tipo del documento:
Article
Pais de publicación:
Estados Unidos